医学
DLCO公司
特发性肺纤维化
内科学
肺活量
病历
回顾性队列研究
扩散能力
吡非尼酮
肺功能测试
慢性阻塞性肺病
肺
物理疗法
外科
肺功能
作者
성은 홍,성우 강,지원 박,권준 장,수현 박,관일 김,영민 부,희재 정,범준 이
出处
期刊:The Journal of Internal Korean Medicine
[The Society of Internal Korean Medicine]
日期:2021-06-30
卷期号:42 (3): 375-384
被引量:1
标识
DOI:10.22246/jikm.2021.42.3.375
摘要
Objective: This study was designed to analyze the clinical features of idiopathic pulmonary fibrosis patients who attended a Korean medicine hospital and the treatment effects through retrospective chart reviews.Methods: The medical records of 82 outpatients who had been diagnosed with idiopathic pulmonary fibrosis and visited the Allergy, Immune, and Respiratory System Department of Kyung Hee Korean Medicine Hospital from 8 January 2015 to 8 January 2021 were retrospectively reviewed. To assess the treatment outcomes, we used the FVC (Forced Vital Capacity), DLCO (Diffusing capacity of the Lung for CO), 6-minute walk test, and HRCT (High Resolution Computed Tomography).Results: The study group consisted of 28 females and 54 males. The median age of the patients was 67.98±11.44 years. The chief complaints were cough (n=51) and dyspnea (n=49). Other frequent symptoms were general weakness (n=8), weight loss (n=4), and a fever (n=2). A total of 77 (93.90%) patients were prescribed Korean herbal medicine, and 52 (63.41%) patients were treated with acupuncture, moxibustion, cupping therapy, ICT, or pharmacopuncture. After treatments, FVC, DLCO, the 6-minute walk test, and HRCT were maintained or worsened slightly.Conclusions: This study presented the characteristics of idiopathic pulmonary fibrosis patients treated by Korean medical therapies, and further studies of Korean medical treatments for idiopathic pulmonary fibrosis patients would be valuable.
科研通智能强力驱动
Strongly Powered by AbleSci AI